Evidence map›Paper›PMID 38462913›Full record

ArticleIntegrative cancer therapies

Integration of Network Pharmacology and Experimental Validation to Explore Jixueteng - Yinyanghuo Herb Pair Alleviate Cisplatin-Induced Myelosuppression.

Yi Liu, Shuying Dai, Yixiao Xu, Yuying Xiang, Yao Zhang, Zeting Xu, Lin Sun, Gao-Chen-Xi Zhang, Qijin Shu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Integrative cancer therapies. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yi LiuThe First School of Clinical Medicine of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Shuying DaiThe First School of Clinical Medicine of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Yixiao XuSchool of Pharmaceutical Sciences of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Yuying XiangThe First School of Clinical Medicine of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.ORCID 0000-0001-8991-7066
Yao ZhangThe First School of Clinical Medicine of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Zeting XuThe First School of Clinical Medicine of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Lin SunZhejiang Provincial Hospital of Chinese Medicine, Hangzhou, China.
Gao-Chen-Xi ZhangZhejiang Provincial Hospital of Chinese Medicine, Hangzhou, China.
Qijin ShuZhejiang Provincial Hospital of Chinese Medicine, Hangzhou, China.
Zhejiang Chinese Medical University · CNZhejiang Provincial Hospital of TCM · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Jixueteng, the vine of the bush

Indexed as

CisplatinDrugs, Chinese HerbalAnimalsCaspase 3FemaleMiceMice, Inbred C57BLMitogen-Activated Protein Kinase KinasesNetwork PharmacologyCaspase 3CisplatinDrugs, Chinese HerbalMitogen-Activated Protein Kinase Kinasescisplatinepimedium sagittatummyelosuppressionsuberect Spatholobus stemtraditional Chinese medicine

Identifiers

PMID38462913
PMCPMC10929034
OpenAlexW4392650834

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.